- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Gene Therapy in Oncology industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Ziopharm Oncology
Oncosec
Intellia Therapeutics
Idera Pharmaceuticals
Merck
Bio-Path Holdings
Marsala Biotech
Oncotelic
Shenzhen SiBiono GeneTech
Bristol-Myers Squibb
Johnson & Johnson
Editas Medicine
CRISPR Therapeutics
Mologen AG
Cold Genesys
UniQure
Tocagen
Sillajen Biotherapeutics
Geron Corp
Oncolytics Biotech
Amgen
AstraZeneca
Advantagene
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Ex Vivo
In Vivo
Application:
Hospitals
Diagnostics Centers
Research Institutes
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Gene Therapy in Oncology Industry Overview
-
1.1.1 Gene Therapy in Oncology Market Scope and Market Segments
-
1.1.2 Gene Therapy in Oncology Industry Characteristics
-
1.1.3 Global and China Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Gene Therapy in Oncology Production Value and Growth Rate (2017-2028)
-
1.2 Global Gene Therapy in Oncology Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Ex Vivo
-
1.2.2 In Vivo
-
1.3 Global Gene Therapy in Oncology Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospitals
-
1.3.2 Diagnostics Centers
-
1.3.3 Research Institutes
-
1.4 Market Analysis by Region
-
1.4.1 North America Gene Therapy in Oncology Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Gene Therapy in Oncology Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Gene Therapy in Oncology Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Gene Therapy in Oncology Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Gene Therapy in Oncology Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Gene Therapy in Oncology Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Gene Therapy in Oncology Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Gene Therapy in Oncology Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Gene Therapy in Oncology Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Gene Therapy in Oncology Industry Porter's Five Forces Model Analysis
-
2.2.3 Gene Therapy in Oncology Industry PEST Analysis
-
2.3 Gene Therapy in Oncology Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Gene Therapy in Oncology Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Gene Therapy in Oncology Industry
Chapter 3 Global and China Gene Therapy in Oncology Market, by Manufacturer
-
3.1 Global and China Gene Therapy in Oncology Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Gene Therapy in Oncology Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Gene Therapy in Oncology Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Gene Therapy in Oncology Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Gene Therapy in Oncology Market Top 3 Players
Chapter 4 Global and China Gene Therapy in Oncology Market, by Type (2017-2028)
-
4.1 Gene Therapy in Oncology Market Trend, by Type
-
4.2 Global Gene Therapy in Oncology Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Gene Therapy in Oncology Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Gene Therapy in Oncology Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Gene Therapy in Oncology Price Trend, by Type (2017-2028)
-
4.3 China Gene Therapy in Oncology Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Gene Therapy in Oncology Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Gene Therapy in Oncology Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Gene Therapy in Oncology Price Trend, by Type (2017-2028)
Chapter 5 Global and China Gene Therapy in Oncology Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Gene Therapy in Oncology Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Gene Therapy in Oncology Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Gene Therapy in Oncology Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Gene Therapy in Oncology Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Gene Therapy in Oncology Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Gene Therapy in Oncology Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Gene Therapy in Oncology Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Gene Therapy in Oncology Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Gene Therapy in Oncology Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Gene Therapy in Oncology Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Gene Therapy in Oncology Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Gene Therapy in Oncology Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Gene Therapy in Oncology Market Analysis
-
7.1 North America Gene Therapy in Oncology Market, by Type
-
7.2 North America Gene Therapy in Oncology Market, by Application
-
7.3 North America Gene Therapy in Oncology Market Analysis and Forecast, by Country
-
7.3.1 United States Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Gene Therapy in Oncology Market Analysis
-
8.1 Europe Gene Therapy in Oncology Market, by Type
-
8.2 Europe Gene Therapy in Oncology Market, by Application
-
8.3 Europe Gene Therapy in Oncology Market Analysis and Forecast, by Country
-
8.3.1 Germany Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Gene Therapy in Oncology Market Analysis
-
9.1 APAC Gene Therapy in Oncology Market, by Type
-
9.2 APAC Gene Therapy in Oncology Market, by Application
-
9.3 APAC Gene Therapy in Oncology Market Analysis and Forecast, by Country
-
9.3.1 China Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Gene Therapy in Oncology Market Analysis
-
10.1 Latin America, Middle East and Africa Gene Therapy in Oncology Market, by Type
-
10.2 Latin America, Middle East and Africa Gene Therapy in Oncology Market, by Application
-
10.3 Latin America, Middle East and Africa Gene Therapy in Oncology Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Gene Therapy in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Gene Therapy in Oncology Company Profiles
-
11.1 Ziopharm Oncology
-
11.1.1 Ziopharm Oncology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Ziopharm Oncology Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.1.3 Ziopharm Oncology Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Oncosec
-
11.2.1 Oncosec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Oncosec Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.2.3 Oncosec Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Intellia Therapeutics
-
11.3.1 Intellia Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Intellia Therapeutics Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.3.3 Intellia Therapeutics Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Idera Pharmaceuticals
-
11.4.1 Idera Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Idera Pharmaceuticals Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.4.3 Idera Pharmaceuticals Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Merck
-
11.5.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Merck Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.5.3 Merck Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Bio-Path Holdings
-
11.6.1 Bio-Path Holdings Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Bio-Path Holdings Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.6.3 Bio-Path Holdings Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Marsala Biotech
-
11.7.1 Marsala Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Marsala Biotech Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.7.3 Marsala Biotech Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Oncotelic
-
11.8.1 Oncotelic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Oncotelic Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.8.3 Oncotelic Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Shenzhen SiBiono GeneTech
-
11.9.1 Shenzhen SiBiono GeneTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.9.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Bristol-Myers Squibb
-
11.10.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Bristol-Myers Squibb Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.10.3 Bristol-Myers Squibb Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Johnson & Johnson
-
11.11.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Johnson & Johnson Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.11.3 Johnson & Johnson Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Editas Medicine
-
11.12.1 Editas Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Editas Medicine Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.12.3 Editas Medicine Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 CRISPR Therapeutics
-
11.13.1 CRISPR Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 CRISPR Therapeutics Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.13.3 CRISPR Therapeutics Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Mologen AG
-
11.14.1 Mologen AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Mologen AG Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.14.3 Mologen AG Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 Cold Genesys
-
11.15.1 Cold Genesys Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 Cold Genesys Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.15.3 Cold Genesys Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 UniQure
-
11.16.1 UniQure Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 UniQure Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.16.3 UniQure Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 Tocagen
-
11.17.1 Tocagen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 Tocagen Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.17.3 Tocagen Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.18 Sillajen Biotherapeutics
-
11.18.1 Sillajen Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.18.2 Sillajen Biotherapeutics Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.18.3 Sillajen Biotherapeutics Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.19 Geron Corp
-
11.19.1 Geron Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.19.2 Geron Corp Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.19.3 Geron Corp Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.20 Oncolytics Biotech
-
11.20.1 Oncolytics Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.20.2 Oncolytics Biotech Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.20.3 Oncolytics Biotech Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.21 Amgen
-
11.21.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.21.2 Amgen Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.21.3 Amgen Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.22 AstraZeneca
-
11.22.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.22.2 AstraZeneca Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.22.3 AstraZeneca Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.23 Advantagene
-
11.23.1 Advantagene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.23.2 Advantagene Gene Therapy in Oncology Product Profiles, Application and Specification
-
11.23.3 Advantagene Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Gene Therapy in Oncology Industry Investment Prospect and Risk Assessment
-
12.1 Gene Therapy in Oncology Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Gene Therapy in Oncology Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure China Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Global Gene Therapy in Oncology Production Value and Growth Rate (2017-2028)
-
Figure China Gene Therapy in Oncology Production Value and Growth Rate (2017-2028)
-
Figure Global Gene Therapy in Oncology Market Size and Growth Rate of Ex Vivo (2017-2028)
-
Figure Global Gene Therapy in Oncology Market Size and Growth Rate of In Vivo (2017-2028)
-
Figure Global Gene Therapy in Oncology Market Size and Growth Rate of Hospitals (2017-2028)
-
Figure Global Gene Therapy in Oncology Market Size and Growth Rate of Diagnostics Centers (2017-2028)
-
Figure Global Gene Therapy in Oncology Market Size and Growth Rate of Research Institutes (2017-2028)
-
Figure North America Gene Therapy in Oncology Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Gene Therapy in Oncology Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Gene Therapy in Oncology Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Gene Therapy in Oncology Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Gene Therapy in Oncology Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Gene Therapy in Oncology Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Gene Therapy in Oncology Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Gene Therapy in Oncology Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Gene Therapy in Oncology Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Gene Therapy in Oncology Market Share, by Manufacturer in 2021
-
Figure Global and China Gene Therapy in Oncology Market Share, by Manufacturer in 2022
-
Table Global Gene Therapy in Oncology Sales Volume, by Type (2017-2028)
-
Table Global Gene Therapy in Oncology Sales Volume Share, by Type (2017-2028)
-
Figure Global Gene Therapy in Oncology Sales Volume Share, by Type (2017-2028)
-
Table Global Gene Therapy in Oncology Sales Value, by Type (2017-2028)
-
Table Global Gene Therapy in Oncology Sales Value Share, by Type (2017-2028)
-
Figure Global Gene Therapy in Oncology Price Trend, by Type (2017-2028)
-
Table China Gene Therapy in Oncology Sales Volume, by Type (2017-2028)
-
Table China Gene Therapy in Oncology Sales Volume Share, by Type (2017-2028)
-
Figure China Gene Therapy in Oncology Sales Volume Share, by Type (2017-2028)
-
Table China Gene Therapy in Oncology Sales Value, by Type (2017-2028)
-
Table China Gene Therapy in Oncology Sales Value Share, by Type (2017-2028)
-
Figure China Gene Therapy in Oncology Price Trend, by Type (2017-2028)
-
Table Global Gene Therapy in Oncology Sales Volume, by Application (2017-2028)
-
Table Global Gene Therapy in Oncology Sales Volume Share, by Application (2017-2028)
-
Figure Global Gene Therapy in Oncology Sales Volume Share, by Application (2017-2028)
-
Table Global Gene Therapy in Oncology Sales Value, by Application (2017-2028)
-
Table Global Gene Therapy in Oncology Sales Value Share, by Application (2017-2028)
-
Figure Global Gene Therapy in Oncology Sales Value Share, by Application (2017-2028)
-
Table China Gene Therapy in Oncology Sales Volume, by Application (2017-2028)
-
Table China Gene Therapy in Oncology Sales Volume Share, by Application (2017-2028)
-
Figure China Gene Therapy in Oncology Sales Volume Share, by Application (2017-2028)
-
Table China Gene Therapy in Oncology Sales Value, by Application (2017-2028)
-
Table China Gene Therapy in Oncology Sales Value Share, by Application (2017-2028)
-
Figure China Gene Therapy in Oncology Sales Value Share, by Application (2017-2028)
-
Figure China Gene Therapy in Oncology Production, Import, Consumption and Export (2017-2022)
-
Figure North America Gene Therapy in Oncology Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Gene Therapy in Oncology Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Gene Therapy in Oncology Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Gene Therapy in Oncology Production, Import, Consumption and Export (2017-2022)
-
Table North America Gene Therapy in Oncology Sales Volume, by Type (2017-2028)
-
Table North America Gene Therapy in Oncology Sales Volume Share, by Type (2017-2028)
-
Figure North America Gene Therapy in Oncology Sales Volume Share, by Type (2017-2028)
-
Table North America Gene Therapy in Oncology Sales Volume, by Application (2017-2028)
-
Table North America Gene Therapy in Oncology Sales Volume Share, by Application (2017-2028)
-
Figure North America Gene Therapy in Oncology Sales Volume Share, by Application (2017-2028)
-
Figure United States Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure United States Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Canada Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Table Europe Gene Therapy in Oncology Sales Volume, by Type (2017-2028)
-
Table Europe Gene Therapy in Oncology Sales Volume Share, by Type (2017-2028)
-
Figure Europe Gene Therapy in Oncology Sales Volume Share, by Type (2017-2028)
-
Table Europe Gene Therapy in Oncology Sales Volume, by Application (2017-2028)
-
Table Europe Gene Therapy in Oncology Sales Volume Share, by Application (2017-2028)
-
Figure Europe Gene Therapy in Oncology Sales Volume Share, by Application (2017-2028)
-
Figure Germany Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure UK Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure UK Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure France Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure France Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Italy Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Spain Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Poland Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Russia Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Table APAC Gene Therapy in Oncology Sales Volume, by Type (2017-2028)
-
Table APAC Gene Therapy in Oncology Sales Volume Share, by Type (2017-2028)
-
Figure APAC Gene Therapy in Oncology Sales Volume Share, by Type (2017-2028)
-
Table APAC Gene Therapy in Oncology Sales Volume, by Application (2017-2028)
-
Table APAC Gene Therapy in Oncology Sales Volume Share, by Application (2017-2028)
-
Figure APAC Gene Therapy in Oncology Sales Volume Share, by Application (2017-2028)
-
Figure China Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure China Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Japan Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure India Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure India Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapy in Oncology Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapy in Oncology Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Gene Therapy in Oncology Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapy in Oncology Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapy in Oncology Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Gene Therapy in Oncology Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Gene Therapy in Oncology Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Gene Therapy in Oncology Sales Value and Growth Rate (2017-2028)
-
Table Ziopharm Oncology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ziopharm Oncology Product Profiles, Application and Specification
-
Table Ziopharm Oncology Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Oncosec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Oncosec Product Profiles, Application and Specification
-
Table Oncosec Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Intellia Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Intellia Therapeutics Product Profiles, Application and Specification
-
Table Intellia Therapeutics Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Idera Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Idera Pharmaceuticals Product Profiles, Application and Specification
-
Table Idera Pharmaceuticals Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bio-Path Holdings Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bio-Path Holdings Product Profiles, Application and Specification
-
Table Bio-Path Holdings Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Marsala Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Marsala Biotech Product Profiles, Application and Specification
-
Table Marsala Biotech Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Oncotelic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Oncotelic Product Profiles, Application and Specification
-
Table Oncotelic Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shenzhen SiBiono GeneTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shenzhen SiBiono GeneTech Product Profiles, Application and Specification
-
Table Shenzhen SiBiono GeneTech Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Johnson & Johnson Product Profiles, Application and Specification
-
Table Johnson & Johnson Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Editas Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Editas Medicine Product Profiles, Application and Specification
-
Table Editas Medicine Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CRISPR Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CRISPR Therapeutics Product Profiles, Application and Specification
-
Table CRISPR Therapeutics Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Mologen AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mologen AG Product Profiles, Application and Specification
-
Table Mologen AG Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Cold Genesys Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Cold Genesys Product Profiles, Application and Specification
-
Table Cold Genesys Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table UniQure Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table UniQure Product Profiles, Application and Specification
-
Table UniQure Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Tocagen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Tocagen Product Profiles, Application and Specification
-
Table Tocagen Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sillajen Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sillajen Biotherapeutics Product Profiles, Application and Specification
-
Table Sillajen Biotherapeutics Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Geron Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Geron Corp Product Profiles, Application and Specification
-
Table Geron Corp Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Oncolytics Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Oncolytics Biotech Product Profiles, Application and Specification
-
Table Oncolytics Biotech Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Product Profiles, Application and Specification
-
Table AstraZeneca Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Advantagene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Advantagene Product Profiles, Application and Specification
-
Table Advantagene Gene Therapy in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-

Chinese